EarlyHealth works closely with (bio)pharmaceutical companies to ensure their products reach the unmet needs of patients in territories that may not see registration within the first year of product launch. Acting as a bridge between patient and manufacturer, EarlyHealth manages the regulatory and imports for each patient to access the medication in a controlled, regulated and transparent way, ensuring product and patient safety.
Medicine used as an adjunct to surgery for subsequent removal of the tumor to prevent or delay amputation in Adults.
A medicine used to prevent excessive bleeding in adults with thrombocytopenia due to long-standing liver disease.
A biosimilar used to treat paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and neuromyelitis optica.
An anti-interferon-gamma antibody used for the treatment of hemophagocytic lymphohistiocytosis.
A medicine used to treat adults with autosomal dominant polycystic kidney disease.
A medication used to slow the effects of hereditary tyrosinemia type 1.
Cabozantinib belongs to a class of drugs known as tyrosine kinase inhibitors. It works by slowing or stopping the growth of cancer cells.